Sunflower Pharmaceuticals Group Co. Ltd. | Ownership
Companies that own Sunflower Pharmaceuticals Group Co. Ltd.
HSBC Jintrust Management Co., Ltd.
8,007,354
1.55%
8,007,354
1.1%
09/30/2017
Yinhua Fund Management Co., Ltd.
5,193,870
1%
5,193,870
0.24%
12/31/2017
China Investment Corp. (Investment Management)
4,900,400
0.95%
0
0.04%
09/30/2017
Huatai-PineBridge Fund Management Co., Ltd.
4,195,872
0.81%
4,195,872
0.25%
09/30/2017
Ping An Asset Management Co., Ltd.
2,400,114
0.46%
1,234,114
0.03%
09/30/2017
ICBC Credit Suisse Asset Management Co., Ltd.
1,591,184
0.31%
1,591,184
0.06%
12/31/2017
China Asset Management Co., Ltd.
999,870
0.19%
999,870
0.01%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
915,454
0.18%
911,054
0.09%
12/31/2017
Guotai Asset Management Co., Ltd.
852,686
0.17%
852,686
0.04%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
716,564
0.14%
716,564
0.16%
12/31/2017
| Address |
No. 18 Donghu Road, Jizhong Area
Harbin Heilongjiang 150078
China
|
|
Employees
|
- |
| Website |
http://www.kuihuayaoye.com |
| Updated |
07/08/2019 |
| Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceutical products. It focuses on proprietary Chinese medicines, chemical drugs, bio-pharmaceuticals, and tonic health care products. Its products include children's medication, digestive system medication, respiratory and cold medicine, gynecological drugs, rheumatism bone disease medication, and cardiovascular and cerebrovascular drugs. |
